Whereas, TEAD4 was significantly higher in tumor samples compared to normal ovarian samples in both the TCGA and GSE26712 cohorts (p<0.05 p=5.8e-07) (Supplementary Figures S1B, C). The gene discussed is TEAD4; the disease is neoplasm.